EQUASENS : Modalités de mise à disposition du rapport financier semestriel 2022
September 30, 2022 12:00 ET
|
EQUASENS
Villers-lès-Nancy, le 30 septembre 2022 - 18h00 (CET) COMMUNIQUE DE PRESSE EQUASENS annonce la publication de son rapport financier semestriel au 30 juin 2022 EQUASENS annonce que son rapport...
EQUASENS : Résultats Semestriels 2022
September 22, 2022 12:00 ET
|
EQUASENS
Villers-lès-Nancy, le 22 septembre 2022 - 18h00 (CET) COMMUNIQUE DE PRESSE Résultats Semestriels 2022 Poursuite de la croissance : Chiffre d’affaires : +10,30% à 103,57 M€ Résultat...
EQUASENS: H1 2022 Results
September 22, 2022 12:00 ET
|
EQUASENS
Villers-lès-Nancy, 22 September 2022 - 6:00 p.m. (CET) PRESS RELEASE H1 2022 Results Continuing growth: Revenue: +10.30% to €103.57m Current Operating Income: +5.37% to €25.76m Net Profit:...
EQUASENS (ex-PHARMAGEST INTERACTIVE) : Chiffre d’affaires du 1er semestre 2022
August 03, 2022 12:00 ET
|
EQUASENS
Villers-lès-Nancy, le 3 août 2022 - 18h00 (CET) COMMUNIQUE DE PRESSE Chiffre d’affaires du 1er semestre 2022 Progression de +10,3% à 103,57 M€. A périmètre comparable (hors acquisition de PROKOV...
EQUASENS (ex-Pharmagest Interactive): H1 2022 Revenue
August 03, 2022 12:00 ET
|
EQUASENS
Villers-lès-Nancy, 3 August 2022 - 6:00 p.m. (CET) PRESS RELEASE H1 2022 Revenue Up 10.3% to €103.57m. Like-for-like (excl. the PROKOV EDITIONS acquisition), Group revenue grows 7.68% to €101.11m....
EQUASENS (ex - PHARMAGEST INTERACTIVE) : Le Groupe complète 3 prises de participation majoritaire
July 28, 2022 12:00 ET
|
EQUASENS
Villers-lès-Nancy, le 28 juillet 2022 - 18h00 (CET) COMMUNIQUE DE PRESSE LE GROUPE EQUASENS (anciennement PHARMAGEST INTERACTIVE) COMPLETE 3 PRISES DE PARTICIPATION MAJORITAIRE Le Groupe Equasens...
Equasens Group (ex Pharmagest Interactive): Complition of three majority acquisitions
July 28, 2022 12:00 ET
|
EQUASENS
Villers-lès-Nancy, 28 July 2022- 6:00 p.m. (CET) PRESS RELEASE EQUASENS GROUP (formerly PHARMAGEST INTERACTIVE)COMPLETES THREE MAJORITY ACQUISITIONS Equasens Group now owns: 76.11% of CAREMEDS...
Definitive Healthcare launches Passport Express to provide ready-to-use healthcare commercial intelligence for biopharma
July 26, 2022 08:30 ET
|
Definitive Healthcare Corp.
FRAMINGHAM, Mass., July 26, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced the general availability of...
TruMed Systems Awarded Group Purchasing Agreement with Premier, Inc
July 25, 2022 09:00 ET
|
TruMed Systems
SAN DIEGO, July 25, 2022 (GLOBE NEWSWIRE) -- TruMed® Systems, the fastest growing medication, vaccine and inventory management solution company has been awarded a group purchasing contract with...
EQUASENS (ex Pharmagest Interactive) intègre le nouveau segment Euronext TECH LEADERS
June 27, 2022 01:00 ET
|
EQUASENS
Villers-lès-Nancy, le 27 juin 2022 - 07h00 (CET) COMMUNIQUE DE PRESSE EQUASENS (anciennement PHARMAGEST INTERACTIVE) intègre le nouveau segment Euronext TECH LEADERS Le Groupe Equasens (Euronext...